Justin W. Yorke - Dec 3, 2021 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role: Director
Signature: s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol: PCSA
Transactions as of: Dec 3, 2021
Transactions value $: -$46,383
Form type: 4
Date filed: 12/7/2021, 03:36 PM
Previous filing: Mar 31, 2022
Next filing: Jan 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCSA	Common Stock	Sale	-$26.6K	-5.5K	-1.01%	$4.84	539K	Dec 3, 2021	By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC	F1
transaction	PCSA	Common Stock	Sale	-$19.8K	-4.2K	-0.78%	$4.71	534K	Dec 6, 2021	By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC	F2
holding	PCSA	Common Stock						9.32K	Dec 3, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8001 to $5.01, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.5601 to $4.80, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Content

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8001 to $5.01, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.5601 to $4.80, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.